Mosapramine

NERVOUS SYSTEM

Key facts

Mosapramine is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including DRD4. Recorded indications include Schizophrenia.

• Molecular targets: DRD4 (1 listed in DrugCentral).
• Indications: Schizophrenia.
• ATC code: N05AX10 (Other antipsychotics).
• Molecular formula: C28H35ClN4O; molecular weight 479.07 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Schizophrenia

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
D(4) dopamine receptor	DRD4	unknown	Ki 10.52

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
—	PMDA	—	—

ATC classification

ATC code	Therapeutic hierarchy
N05AX10	NERVOUS SYSTEM › PSYCHOLEPTICS › ANTIPSYCHOTICS › Other antipsychotics

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Mosapramine is on its molecule page.

• Molecular formula: C₂₈H₃₅ClN₄O
• Molecular weight: 479.07 g/mol
• CAS number: 89419-40-9
• InChIKey: PXUIZULXJVRBPC-UHFFFAOYSA-N
• PubChem CID: 4257

ClC1=CC=C2CCC3=C(C=CC=C3)N(CCCN3CCC4(CC3)N3CCCCC3NC4=O)C2=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Mosapramine used for?

DrugCentral lists the following indications for Mosapramine: Schizophrenia.

How does Mosapramine work?

Its molecular targets in DrugCentral include DRD4.

What is the chemical formula of Mosapramine?

Mosapramine has the molecular formula C28H35ClN4O and a molecular weight of 479.07 g/mol.

Sources

• DrugCentral drug card 1847 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL2106650 — compound record and bioactivity
• PubChem CID 4257 — chemical identifiers
• DrugBank DB13676 — drug record
• FDA UNII 04UZQ7O9SJ — substance identity
• UniProt P21917 (DRD4) — target protein

How this page is built: methodology · editorial policy & corrections.